NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1225017007 MD
Verify on CMS → Frank Ramharrack, MD
Endocrinology, Diabetes & Metabolism Physician in Ocala, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,871 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
4K
Medicare Part D claims · 920 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
41%
generic claims · 48% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
CMS neutral threshold · no category scores published
Industry payments
$50.23
2 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Frank Ramharrack, MD carries the neutral CMS MIPS final score of 75/100, assigned where no category was scored - and filed 4,380 Medicare Part D claims in 2023.
- 75/100
- CMS neutral score · not measured
- 4K
- Part D claims, 2023
- 41%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Frank Ramharrack, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
4,380 ≥ 92nd percentile 92% of 1,370,886 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Frank Ramharrack, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Frank Ramharrack, MD?
CMS neutral score, not measuredPrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
4,380 66% vs specialty avg
MIPS final score
75/100
Specialty distribution in Florida
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Florida providers
MIPS score not measured
CMS assigned a neutral 75/100 threshold
CMS did not publish any Quality, Cost, Promoting Interoperability, or Improvement Activities category score for this clinician. This administrative threshold is not comparable with the national average of clinicians whose MIPS score was measured.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Frank Ramharrack, MD appears in the CMS NPPES registry as an Endocrinology, Diabetes & Metabolism Physician provider holding MD credentials at 311 SE 29TH PL, Ocala, FL, 34471, with a listed phone of (352) 369-1411. NPI 1225017007 was issued on 01/11/2006.
Medicare Part D records for calendar year 2023 show 4,380 prescription claims written by this provider, covering 920 Medicare beneficiaries and totaling roughly $1.8 million in drug spend, split 48% brand-name and 41% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider carries a Final Score of 75/100 for the 2023 performance year, but CMS published no Quality, Promoting Interoperability, Improvement Activity or Cost score: this is the neutral performance threshold CMS assigns where nothing was scored, so it is not comparable with clinicians whose score was measured.
Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,871 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1225017007 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 01/11/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
CMS neutral threshold · not measured
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Frank Ramharrack, MD. Source: openpaymentsdata.cms.gov.
Total received
$50
Largest payer
Medtronic, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Frank Ramharrack, MD. To verify Frank Ramharrack, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Frank Ramharrack, MD - brand share 48.0%
Endocrinology, Diabetes & Metabolism Physician average
48% brand-name claims vs 41% generic, on 4,380 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
4,380
Total Claims
$1.8M
Total Drug Cost
920
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 10,763
- Total Day Supply
- 320,642
- Brand vs Generic
- 48% brand / 41% generic
- Brand Drug Cost
- $1.7M
- Generic Drug Cost
- $42K
Patient Demographics
- Average Patient Age
- 72.3 years
- Avg HCC Risk Score
- 1.82
- Gender Split
- 61% female / 39% male
- Age Distribution
- <65: 113, 65-74: 448, 75-84: 289, 85+: 70
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Frank Ramharrack, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
858 claims
- Methimazole 233
Methimazole
233 claims
- Glimepiride 224
Glimepiride
224 claims
- Metformin Hcl 190
Metformin Hcl
190 claims
- Ozempic 181
Ozempic
181 claims
- Jardiance 162
Jardiance
162 claims
- Synthroid 142
Synthroid
142 claims
- Humalog Mix 75-25 … 110
Humalog Mix 75-25 Kwikpen
110 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 858 |
| Methimazole | 233 |
| Glimepiride | 224 |
| Metformin Hcl | 190 |
| Ozempic Semaglutide | 181 |
| Jardiance Empagliflozin | 162 |
| Synthroid Levothyroxine Sodium | 142 |
| Humalog Mix 75-25 Kwikpen Insulin Lispro Protamin/Lispro | 110 |
| Novolog Mix 70-30 Flexpen Insulin Aspart Prot/Insuln Asp | 100 |
| Metformin Hcl Er Metformin Hcl | 70 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in FL →
All providers in Florida →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Frank Ramharrack, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
7,871
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider
Frank Ramharrack, MD's 4,380 claims are above the specialty average of 2,639.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Ramharrack.
Dr. Ejigayehu Abate
MD
Jacksonville, FL
Dr. Susan Abend
M.D.
Sarasota, FL
Dr. Daisy Acevedo Morales
MD
South Miami, FL
Dr. Brenda Acosta Ashby
MD
Doral, FL
Dr. Adriane Adami
APRN
Panama City, FL
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Florida medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Endocrinology, Diabetes & Metabolism Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Florida
Frequently Asked Questions
What is Frank Ramharrack, MD's specialty? ▼
Frank Ramharrack, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Ocala, Florida. Credentials: MD.
How much does Frank Ramharrack, MD prescribe under Medicare Part D? ▼
In 2023, Frank Ramharrack, MD wrote 4,380 Medicare Part D claims totaling $1.8M in drug costs for 920 beneficiaries.
What is Frank Ramharrack, MD's Medicare quality score? ▼
Frank Ramharrack, MD has a CMS MIPS Final Score of 75/100. CMS published no Quality, Promoting Interoperability, Improvement Activity or Cost score for this clinician, so the final score is the neutral performance threshold CMS assigns rather than a measured result. The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Frank Ramharrack, MD located? ▼
Frank Ramharrack, MD is located at 311 SE 29TH PL, Ocala, FL, 34471. Phone: (352) 369-1411.
What is Frank Ramharrack, MD's NPI number? ▼
Frank Ramharrack, MD's National Provider Identifier (NPI) is 1225017007, issued on 01/11/2006.
Does Frank Ramharrack, MD prescribe more brand-name or generic drugs? ▼
Frank Ramharrack, MD's prescribing is 48% brand-name and 41% generic drugs by claim count, with $1.7M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 7,871 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Frank Ramharrack, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Frank Ramharrack, MD's most frequently prescribed drugs include Levothyroxine Sodium, Methimazole, Glimepiride. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Frank Ramharrack, MD accept Medicare? ▼
Frank Ramharrack, MD appears in CMS Medicare data with 4,380 Part D claims and 920 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Frank Ramharrack, MD's credentials? ▼
Frank Ramharrack, MD's NPI is 1225017007 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.